Global Catheters Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Technology;

Cardiovascular Catheter, Urology Catheter, Intravenous Catheter, Neurovascular Catheter, and Specialty Catheter

By Indication;

Urinary Incontinence, Urethral Stricture, Chronic Obstruction, Neurogenic Bladder, Enlarged Prostate Gland/BPH, Prostate Cancer, Acute Kidney Injury, and Others

By Distribution Channel;

Hospital Stores, Retail Stores, and Others

By End user;

Hospitals, Dialysis Centers, Long-Term Care Facilities, Ambulatory Surgical Centers, and Home Care

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn440766717 Published Date: May, 2025 Updated Date: June, 2025

Introduction

Global Catheters Market (USD Million), 2021 - 2031

Catheters Market was valued at USD 55,498.84 million in the year 2024. The size of this market is expected to increase to USD 86,642.04 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.6%.


Global Catheters Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 6.6 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.6 %
Market Size (2024)USD 55,498.84 Million
Market Size (2031)USD 86,642.04 Million
Market ConcentrationMedium
Report Pages355
55,498.84
2024
86,642.04
2031

Major Players

  • Boston Scientific Corporation
  • Coloplast
  • Abbott
  • Johnson & Johnson
  • Arrow International Inc
  • Smiths Medical
  • Edwards Life Sciences Corporation
  • Medtronic Inc
  • Rochester Medical Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Catheters Market

Fragmented - Highly competitive market without dominant players


The Catheters Market continues to experience robust growth, propelled by the increasing adoption of minimally invasive medical procedures. Catheters have become fundamental tools in healthcare delivery, with approximately 70% of all procedures utilizing catheter-based techniques for diagnosis or treatment. Their versatility and efficiency are enhancing outcomes across clinical settings.

Chronic Illnesses Driving Utilization
The surge in chronic health conditions, particularly cardiovascular and renal diseases, is fueling catheter demand. Data indicates that nearly 60% of in-patient chronic care involves catheter-assisted procedures for monitoring or intervention. This trend reflects the growing importance of catheters in disease management strategies.

Innovative Product Development Enhancing Performance
Breakthroughs in catheter engineering, including the use of biocompatible materials, infection-resistant coatings, and real-time sensing capabilities, are revolutionizing the market. Currently, over 40% of new catheter introductions incorporate such advancements, offering enhanced safety and improved clinical precision.

Policy Backing and Infrastructure Development
Increasing healthcare expenditure and policy initiatives focused on expanding medical access are reinforcing market momentum. Over 50% of publicly funded healthcare programs now prioritize catheter supply as a critical component of their procurement strategies. These developments are ensuring broader availability and sustained growth.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Technology
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Catheters Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological Advancements
        2. Rising Geriatric Population
        3. Increasing Prevalence of Chronic Diseases
        4. Growing Surgical Procedures
        5. Expanding Healthcare Expenditure
      2. Restraints
        1. Stringent Regulatory Framework
        2. Complications and Risks Associated with Catheterization
        3. High Cost of Catheterization Procedures
        4. Product Recalls and Safety Concerns
        5. Limited Reimbursement Policies
      3. Opportunities
        1. Expansion in Emerging Markets
        2. Development of Innovative Catheter Technologies
        3. Focus on Home Healthcare Settings
        4. Strategic Collaborations and Partnerships
        5. Increasing Adoption of Minimally Invasive Procedures
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Catheters Market, By Technology, 2021 - 2031 (USD Million)
      1. Cardiovascular Catheter
      2. Urology Catheter
      3. Intravenous Catheter
      4. Neurovascular Catheter
      5. Specialty Catheter
    2. Global Catheters Market, By Indication, 2021 - 2031 (USD Million)
      1. Urinary Incontinence
      2. Urethral Stricture
      3. Chronic Obstruction
      4. Neurogenic Bladder
      5. Enlarged Prostate Gland/BPH
      6. Prostate Cancer
      7. Acute Kidney Injury
      8. Others
    3. Global Catheters Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Hospital Stores
      2. Retail Stores
      3. Others.
    4. Global Catheters Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Dialysis Centers
      3. Long-term Care Facilities
      4. Ambulatory Surgical Centers
      5. Home Care
    5. Global Catheters Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boston Scientific Corporation
      2. Coloplast
      3. Abbott
      4. Johnson & Johnson
      5. Arrow International Inc
      6. Smiths Medical
      7. Edwards Life Sciences Corporation
      8. Medtronic Inc
      9. Rochester Medical Corporation
  7. Analyst Views
  8. Future Outlook of the Market